Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLC
Public ClinicalTrials.gov record NCT00313768. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Phase 2 Trial Of Paclitaxel, Carboplatin And Bevacizumab With Or Without PF-3512676 As First-Line Treatment Of Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To assess the efficacy and safety of PF-3512676 administered in combination with paclitaxel, carboplatin and bevacizumab as first-line treatment in patients with locally advanced or metastatic nonsquamous non-small cell lung cancer
Study identification
- NCT ID
- NCT00313768
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 23 participants
Conditions and interventions
Conditions
Interventions
- paclitaxel + carboplatin + bevacizumab Drug
- carboplatin + paclitaxel + bevacizumab + PF-3512676 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2005 (Type not available)
- Primary completion
- May 2008 (Actual)
- Completion
- May 2008 (Actual)
- Last update posted
- Sep 28, 2009
2005 – 2008
United States locations
- U.S. sites
- 29
- U.S. states
- 9
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Bessemer | Alabama | 35022 | — |
| Pfizer Investigational Site | Birmingham | Alabama | 32511 | — |
| Pfizer Investigational Site | Birmingham | Alabama | 35205 | — |
| Pfizer Investigational Site | Birmingham | Alabama | 35209 | — |
| Pfizer Investigational Site | Birmingham | Alabama | 35213 | — |
| Pfizer Investigational Site | Birmingham | Alabama | 35235 | — |
| Pfizer Investigational Site | Mobile | Alabama | 36607 | — |
| Pfizer Investigational Site | Fountain Valley | California | 92708 | — |
| Pfizer Investigational Site | Los Angeles | California | 90033 | — |
| Pfizer Investigational Site | Cocoa Beach | Florida | 32931 | — |
| Pfizer Investigational Site | Merritt Island | Florida | 32952 | — |
| Pfizer Investigational Site | Rockledge | Florida | 32955 | — |
| Pfizer Investigational Site | Titusville | Florida | 32796 | — |
| Pfizer Investigational Site | Valdosta | Georgia | 31602 | — |
| Pfizer Investigational Site | Joliet | Illinois | 60432 | — |
| Pfizer Investigational Site | Joliet | Illinois | 60435 | — |
| Pfizer Investigational Site | Baltimore | Maryland | 21231 | — |
| Pfizer Investigational Site | Clinton | North Carolina | 28382 | — |
| Pfizer Investigational Site | Goldsboro | North Carolina | 27534 | — |
| Pfizer Investigational Site | Pollocksville | North Carolina | 28573 | — |
| Pfizer Investigational Site | Wilson | North Carolina | 27893 | — |
| Pfizer Investigational Site | Knoxville | Tennessee | 37920 | — |
| Pfizer Investigational Site | Knoxville | Tennessee | 37934 | — |
| Pfizer Investigational Site | Austin | Texas | 78705 | — |
| Pfizer Investigational Site | Austin | Texas | 78745 | — |
| Pfizer Investigational Site | Austin | Texas | 78758 | — |
| Pfizer Investigational Site | Austin | Texas | 78759 | — |
| Pfizer Investigational Site | Georgetown | Texas | 78626 | — |
| Pfizer Investigational Site | San Marcos | Texas | 78666 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00313768, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 28, 2009 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00313768 live on ClinicalTrials.gov.